Financial Year |
March 31 2023 |
Monetary Funds |
747,521,573.92 |
Held-for-trading Financial Assets |
767,657,753.42 |
Notes Receivable |
-- |
Accounts Receivable |
169,536,969.50 |
Advances to Suppliers |
48,893,708.80 |
Other Receivables |
23,492,226.74 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
158,779,979.08 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
32,983,763.13 |
Total Current Assets |
2,084,720,292.11 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
104,202,843.11 |
Investment Properties |
41,652,681.26 |
Fixed Assetes |
485,462,999.04 |
Under-construction Projects |
32,529,156.81 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
94,750,137.01 |
R&D expenses |
421,719,781.76 |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
36,680,941.79 |
Deferred Income Tax Assets |
23,715,458.28 |
Other Non-Current Assets |
3,701,424.96 |
Sub-Total of Non-Current Assets |
1,258,331,843.31 |
Total Assets |
3,343,052,135.42 |
Short-Term Loans |
45,034,756.95 |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
36,587,669.86 |
Accounts Received In Advance |
266,173.14 |
Employee Compensation Payable |
15,450,807.12 |
Taxes Payable |
12,836,027.84 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
186,095,856.23 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
3,573,855.29 |
Other Current Liabilities |
1,258,270.44 |
Sub-Total of Current Liabilities |
310,782,420.25 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
12,559,128.41 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
87,558,087.12 |
Total Liabilities |
398,340,507.37 |
Paid-In Capital(Or Share Stock) |
928,160,351.00 |
Capital Surplus |
44,237,622.97 |
Surplus Reserve |
248,226,392.26 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
1,660,017,244.80 |
Minority Stockholder's Interest |
51,718,408.63 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,892,993,219.42 |
Owner's Equity(Stockholder's Equity) |
2,944,711,628.05 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
3,343,052,135.42 |